We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Proposes Revisions to Module V of GVPs on Risk Management Systems
EMA Proposes Revisions to Module V of GVPs on Risk Management Systems
The European Medicines Agency has begun a public consultation on planned revisions to Module V of the good pharmacovigilance practices on risk management systems, which clarifies what risk management plans to focus on over a product’s lifecycle.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor